Xeris Biopharma officer plans 16,666-share sale

Beth Hecht’s prior three-month activity includes two 10b5-1 sales of 16,666 shares each, in August and September 2026.

Rhea-AI Filing Summary

Xeris Biopharma Holdings, Inc. officer Beth Hecht reported an intended sale of 16,666 common shares, with an aggregate market value of $159,326.96 and an approximate sale date of October 1, 2026, through Morgan Stanley Smith Barney LLC. Her listed prior three-month sales include 16,666 shares on September 1, 2026, and 16,666 shares on August 3, 2026, each identified as a 10b5-1 sale.

Key Figures

Intended sale: 16,666 common shares Aggregate market value: $159,326.96 Prior 10b5-1 sale: 16,666 shares +3 more

6 metrics

Intended sale 16,666 common shares Beth Hecht; approximate sale date October 1, 2026

Aggregate market value $159,326.96 Intended sale of 16,666 common shares

Prior 10b5-1 sale 16,666 shares September 1, 2026

Prior 10b5-1 sale 16,666 shares August 3, 2026

Shares from restricted stock units 15,229 shares Acquisition date January 29, 2023

Open-market purchase shares 1,437 shares Acquisition date March 13, 2020

Key Terms

Rule 144, 10b5-1 Sales, Restricted Stock Units

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10b5-1 Sales financial

"10b5-1 Sales for BETH HECHT"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Restricted Stock Units financial

"Restricted Stock Units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many XERS shares does Beth Hecht intend to sell?

Beth Hecht reported an intended sale of 16,666 common shares, with an aggregate market value of $159,326.96 and an approximate sale date of October 1, 2026, through Morgan Stanley Smith Barney LLC.

What prior XERS sales did Beth Hecht report?

The prior three-month sales listed for Beth Hecht include 16,666 shares on September 1, 2026, and 16,666 shares on August 3, 2026; both are identified as 10b5-1 sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/01/2026 - 04:26 PM Accepted by SEC EDGAR 10/01/2026 - 04:26 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001652410
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	XERIS BIOPHARMA HOLDINGS, INC.
SEC File Number	001-40880
Address of Issuer	1375 West Fulton Street, Suite 1300 Chicago ILLINOIS 60607
Phone	8444455704
Name of Person for Whose Account the Securities are To Be Sold	BETH HECHT
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	16666	159326.96	182320306	10/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/29/2023	Restricted Stock Units	Issuer			15229	01/29/2023	N/A
Common	03/13/2020	Open Market Purchase	Issuer			1437	03/13/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for BETH HECHT 1375 West Fulton Street, Suite 1300 Chicago IL 60607	Common	09/01/2026	16666	141433.67
10b5-1 Sales for BETH HECHT 1375 West Fulton Street, Suite 1300 Chicago IL 60607	Common	08/03/2026	16666	133553.66

144: Remarks and Signature

Remarks
Date of Notice	10/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/08/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Beth P. Hecht
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)